Syra Health Corp. Class A Common Stock
Other OTCTotal Valuation
Syra Health Corp. Class A Common Stock carries a market capitalization of 8.62M, placing it among publicly traded companies globally. Its enterprise value stands at -278,728.91, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.62M |
| Enterprise Value | -278,728.91 |
Share Statistics
Syra Health Corp. Class A Common Stock currently has 11.94M shares outstanding.
| Shares Outstanding | 11.94M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.34, and the price-to-book ratio stands at -0.27.
| PE Ratio | N/A |
| PS Ratio | 0.34 |
| PB Ratio | -0.27 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | 3.48 |
| P/OCF Ratio | 3.40 |
Financial Position
Syra Health Corp. Class A Common Stock maintains a current ratio of 2.48, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.09, indicating elevated leverage, while an interest coverage ratio of -18.02 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.48 |
| Quick Ratio | 2.40 |
| Debt / Equity | 3.09 |
| Debt / EBITDA | -0.32 |
| Interest Coverage | -18.02 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -4.78 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 1.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Syra Health Corp. Class A Common Stock's stock has gained approximately 538.65546% over the past 52 weeks. The 50-day moving average sits at 0.56, while the 200-day moving average is 0.25.
| Beta (5Y) | N/A |
| 52-Week Price Change | 538.65546% |
| 50-Day Moving Average | 0.56 |
| 200-Day Moving Average | 0.25 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Syra Health Corp. Class A Common Stock generated 7.64M in revenue and converted that into -183,089.00 in net income, yielding earnings per share of -0.01. EBITDA reached -225,282.00, while operating income came in at -240,007.00.
| Revenue | 7.64M |
| Gross Profit | 2.87M |
| Operating Income | -240,007.00 |
| Pretax Income | -183,089.00 |
| Net Income | -183,089.00 |
| EBITDA | -225,282.00 |
| EBIT | -240,007.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Syra Health Corp. Class A Common Stock holds 2.92M in cash and equivalents against 73,086.00 in total debt, resulting in a net debt position of -2.86M. Total book value stands at -9.47M, with working capital of 2.35M providing operational flexibility.
| Cash & Cash Equivalents | 2.92M |
| Total Debt | 73,086.00 |
| Net Debt | -2.86M |
| Equity (Book Value) | -9.47M |
| Book Value Per Share | -0.79 |
| Working Capital | 2.35M |
Cash Flow
Syra Health Corp. Class A Common Stock produced 755,968.00 in operating cash flow over the past twelve months. After subtracting -107.00 in capital expenditures, free cash flow totaled 755,861.00 - equivalent to 0.06 per share.
| Operating Cash Flow | 755,968.00 |
| Capital Expenditures | -107.00 |
| Free Cash Flow | 755,861.00 |
| FCF Per Share | 0.06 |
Margins
Syra Health Corp. Class A Common Stock operates with a gross margin of 37.56, reflecting its pricing power and cost economics. The operating margin of -3.14 and net profit margin of -2.40 provide insight into operational efficiency.
| Gross Margin | 37.56 |
| Operating Margin | -3.14 |
| Pretax Margin | -2.40 |
| Profit Margin | -2.40 |
| EBITDA Margin | -2.95 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 12.61 |
| FCF Yield | 28.74 |
Scores
Syra Health Corp. Class A Common Stock posts an Altman Z-Score of 0.06, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.06 |